Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean sulfur iodine?
Displaying drugs 551 - 575 of 1138 in total
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Chlorfenson is developed by Moberg Derma for the treatment of onychomycosis (nail fungus) as the primary indication.
Investigational
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.
Investigational
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Experimental
Vet approved
Matched Categories: … Sulfur Compounds …
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Matched Categories: … Sulfur Compounds …
Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD. It is under investigation in clinical trial NCT01611805 (Japanese Phase I of GSK1605786).
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE). [PubChem]
Experimental
GDC-0623 has been used in trials studying the treatment of Solid Cancers.
Investigational
Investigational
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds ... Amino Acids, Sulfur
Experimental
Matched Categories: … Sulfur Compounds ... Amino Acids, Sulfur
Experimental
Matched Categories: … Sulfur Compounds …
VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type 1, and Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus.
Investigational
Matched Categories: … Sulfur Compounds …
Elesclomol is a novel, injectable, drug candidate that kills cancer cells by elevating oxidative stress levels beyond a breaking point, triggering programmed cell death. In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy...
Investigational
Matched Categories: … Sulfur Compounds …
QGC001 has been used in trials studying the treatment of Essential Hypertension.
Investigational
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
AVE-1625 is an oral selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant. It is currently developed in obesity and its associated comorbidities. AVE-1625 is also being developed for the treatment of Alzheimer disease.
Investigational
Matched Categories: … Sulfur Compounds …
Dapansutrile is under investigation in clinical trial NCT01768975 (Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee).
Investigational
Matched Categories: … Sulfur Compounds …
Displaying drugs 551 - 575 of 1138 in total